Contents
Certolizumab pegol
Certolizumab pegol, sold under the brand name Cimzia, is a biopharmaceutical medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB. It is on the World Health Organization's List of Essential Medicines.
Medical uses
Method of action
Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha. More precisely, it is a PEGylated Fab' fragment of a humanized TNF inhibitor monoclonal antibody.
Clinical trials
This article is derived from Wikipedia and licensed under CC BY-SA 4.0. View the original article.
Wikipedia® is a registered trademark of the
Wikimedia Foundation, Inc.
Bliptext is not
affiliated with or endorsed by Wikipedia or the
Wikimedia Foundation.